Wave Life Sciences (WVE) Revenue Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3,790.58% |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 316.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316.85% |
| Jun 30, 2025 | -55.82% |
| Mar 31, 2025 | -26.82% |
| Jun 30, 2024 | -10.92% |
| Mar 31, 2024 | -3.02% |
| Dec 31, 2023 | 2,245.12% |
| Sep 30, 2023 | 17,168.07% |
| Jun 30, 2023 | 5,794.93% |
| Mar 31, 2023 | 638.80% |
| Dec 31, 2022 | -29.80% |
| Sep 30, 2022 | -99.22% |
| Jun 30, 2022 | -86.49% |
| Dec 31, 2021 | -81.30% |
| Sep 30, 2021 | 955.74% |
| Jun 30, 2021 | -8.29% |
| Dec 31, 2020 | 293.29% |
| Sep 30, 2020 | 17.79% |
| Jun 30, 2020 | -60.32% |
| Mar 31, 2020 | 37.51% |
| Dec 31, 2019 | -33.70% |
| Sep 30, 2019 | -34.81% |
| Jun 30, 2019 | 56.34% |
| Mar 31, 2019 | 112.80% |
| Dec 31, 2018 | 229.69% |
| Sep 30, 2018 | 241.67% |
| Jun 30, 2018 | 344.76% |
| Mar 31, 2018 | 271.28% |
| Dec 31, 2017 | 62.43% |
| Sep 30, 2017 | 235.46% |
| Jun 30, 2017 | 163.07% |
| Jun 30, 2016 | 230.95% |